UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington D.C., 20549
Form 8-K
Current Report
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date Of Report (Date Of Earliest Event Reported): June 16, 2006
NANOPHASE TECHNOLOGIES CORPORATION
(Exact Name of Registrant as Specified in its Charter)
Commission File Number: 0-22333
| |
|
|
| Delaware
|
|
36-3687863 |
(State or Other Jurisdiction of
Incorporation or Organization)
|
|
(I.R.S. Employer
Identification No.) |
1319 Marquette Drive, Romeoville, Illinois 60446
(Address of Principal Executive Offices, Including Zip Code)
(630) 771-6700
(Registrant’s Telephone Number, Including Area Code)
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following provisions:
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act(17CFR240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange
Act(17CFR240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange
Act(17CFR240.13e-4(c))
TABLE OF CONTENTS
Items
to be Included in this Report
Item 1.01. Entry into a Material Definitive Agreement
On June 16, 2006 Nanophase Technologies Corporation (the “Company”) received a
fully-executed Z-COTE HP-2 Brand Supply Agreement (dated effective May 15, 2006) between the Company and BASF
Corporation, pursuant to which the Company will supply patent-pending surface engineered
nanoparticles for current and future products for BASF’s Z-COTE® MAX brand. A
copy of the Supply Agreement is being furnished as Exhibit 99.1 to this report and is
incorporated herein by reference.
Item 9.01. Financial Statements and Exhibits
99.1 Z-COTE HP-2 Brand Supply Agreement dated May 15, 2006 between Nanophase Technologies Corporation
and BASF Corporation*
|
|
|
| * |
|
Confidentiality requested. Confidential portions have been omitted and filed separately with
the Commission as required by Rule 24b-2. |
Signature(s)
Pursuant to the Requirements of the Securities Exchange Act of 1934, the Registrant has
duly caused this Report to be signed on its behalf by the undersigned hereunto duly
authorized.
| |
|
|
|
|
| |
|
Nanophase Technologies Corporation |
|
|
|
|
|
Date: June 20, 2006
|
|
By:
|
|
/s/ JESS JANKOWSKI |
|
|
|
|
|
|
|
|
|
JESS JANKOWSKI |
|
|
|
|
Chief Financial Officer |